HPN536
HPN536 is a trispecific, T-cell-activating protein-based construct, which binds to mesothelin-expressing tumor cells, CD3ε on T cells, and to serum albumin. HPN536 specifically redirects T cells for potent redirected lysis of mesothelin-expressing cancer cells with concomitant T-cell activation[1].
Product Specifications
UNSPSC
12352203
Target
CD3
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
99.00
Molecular Weight
(52.90 kDa)
References & Citations
[1]Molloy ME, et al. Preclinical Characterization of HPN536, a Trispecific, T-Cell-Activating Protein Construct for the Treatment of Mesothelin-Expressing Solid Tumors. Clin Cancer Res. 2021 Mar 1;27 (5) :1452-1462.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P991088/HPN536-SDS-MedChemExpress.pdf
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6342456-01 0.2 mL
RNASEH2B, ID (RNASEH2B, DLEU8, Ribonuclease H2 subunit B, Aicardi-Goutieres syndrome 2 protein, Deleted in lymphocytic leukemia 8, Ribonuclease HI subunit B) (AP)
Ask
View Details 
MBS6342456-02 5x 0.2 mL
RNASEH2B, ID (RNASEH2B, DLEU8, Ribonuclease H2 subunit B, Aicardi-Goutieres syndrome 2 protein, Deleted in lymphocytic leukemia 8, Ribonuclease HI subunit B) (AP)
Ask
View Details 